Table 3

Univariate and multivariate analyses for the prognoses of early gastric cancer patients

Variables5-year OS rateUnivariateMultivariate
PHR95% CIP
Age (years)0.067
 < 6097.50%
 ≥ 6095.40%
Gender0.678
 Male96.60%
 Female96.00%
Tumor size (cm)0.251
 ≤ 296.80%
 > 295.50%
Tumor location0.68
 Upper97.10%
 Middle95.70%
 Lower96.70%
Gross type0.329
 Ulcerated95.60%
 Non-ulcerated96.80%
Degree of differentiation0.098
 Differentiated97.60%
 Undifferentiated95.70%
Histopathology0.198
 Tub97.60%
 Por94.90%
 Sig97.50%
 Muc100%
 Pap100%
Examined lymph node0.967
Her-2 status< 0.001*
 Negative97.20%
 Positive90.80%3.0821.512–6.2810.002*
Depth of tumor invasion< 0.001*
 T1a98.60%
 T1b94.20%2.0260.832–4.9350.12
LNM status< 0.001*
 Negative98.30%
 Positive84.80%6.7813.347–13.742< 0.001*
Lymphovascular invasion< 0.001*
 Negative97.10%
 Positive88.10%1.3590.605–3.0540.458
Perineural invasion< 0.001*
 Negative96.60%
 Positive75.00%4.0351.122–14.5060.033*

*P < 0.05 was considered statistically significant. Tub, tubular adenocarcinoma; Por, poorly differentiated adenocarcinoma; Sig, signet-ring cell carcinoma; Muc, mucinous adenocarcinoma; Pap, papillary adenocarcinoma; T1a, mucosal invasion; T1b, submucosal invasion; OS, overall survival; HR, hazard ratio; CI, confidence interval.